FacebookXEmail

News

BCRegMed/Victoria Health Hackathon 2018

2018-09-07T00:00:00-07:00September 7th, 2018|Categories: News|

The first ever health and regenerative medicine themed Hackathon is being held in Victoria. Hackathons are focused events which bring together interdisciplinary teams to develop innovative solutions to front-line healthcare problems.  We are recruiting hackers from all backgrounds and experiences, mentors, and judges.   The kick-off event will be held at the University of Victoria - Come out to hear about the challenges and to arrange teams! Challenges posed by the BCRegMed Initiative, the Victoria Hand Project, and Island Health will be presented to the hackers, enabling them to create teams. The teams will have until the hacking weekend to think about their approach to [...]

Read More

The University of Victoria hosts a successful 34th annual meeting of the Canadian Society for Biomaterials

2018-08-15T00:00:00-07:00August 15th, 2018|Categories: News, Newsletter, Trainee Steering Committee|

Dr. Stephanie M. Willerth, conference chair and the 2017-18 President of the Canadian Biomaterials Society (CBS), along with her organizing committee hosted the 34th Annual Meeting of CBS at the University of Victoria during May 16th through 19th. The meeting consisted of a 4-day event attended by 135 people: 90 students, 5 researchers, 25 professors, 15 post-docs, and industry partners. During this meeting, the latest advances on research in the field of Biomaterials and Tissue engineering in Canada were shared and discussed. The event was supported by CBS and external industry funding; Aspect Biosystems as the Gold Sponsor, Rheolution as Silver [...]

Read More

Tackling the world’s deadliest diseases one Ab at a time: An interview with AbCellera’s CEO, Dr. Carl Hansen

2018-08-14T00:00:00-07:00August 14th, 2018|Categories: News, Newsletter, Trainee Steering Committee|

Dr. Carl Hansen, CEO of AbCellera, a Vancouver-based biotech on the hunt for novel antibodies. Can one company simultaneously work on solving the problems of Ebola, influenza, neurodegeneration, cancer, tuberculosis, and enterotoxicogenic E. coli? If you are AbCellera, a Vancouver-based biotech on the hunt for novel antibodies that can be used to fight these diseases, the answer is yes. The company has built the world’s leading platform for the discovery of monoclonal antibodies and the profiling of natural immune responses. This proprietary platform, which uses a combination of microfluidics, genomics, microscopy, and machine learning, allows for screening millions of [...]

Read More

Funding Opportunity:
FY18 Reconstructive Transplant Research Program (RTRP)

2018-07-18T00:00:00-07:00July 18th, 2018|Categories: Announcement, News|

The office of Congressionally Directed Medical Research Programs (CDMRP) has recently released Fiscal Year 2018 (FY18) funding opportunities for the Department of Defense (DoD) Reconstructive Transplant Research Program (RTRP): Concept Award Investigator-Initiated Research Award Qualitative Research Award Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website, the CDMRP website and the electronic Biomedical Research Application Portal (eBRAP). All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website.

Read More

Stem Cell Network invited to submit application for Networks of Centres of Excellence of Canada 2018

2018-03-27T00:00:00-07:00March 27th, 2018|Categories: Announcement, News|

SCN is opening a Call for Letters of Intent (LOI) to stem cell and regenerative medicine researchers across Canada in support of its 2018 Networks of Centres of Excellence application. This is your opportunity to contribute and participate in shaping the future of stem cell research. By submitting your LOI you will empower SCN as we continue to work collectively to build and strengthen stem cell research in Canada. Read More Here!

Read More

A repurposed drug could open door to more stem cell transplants

2017-12-21T00:00:00-08:00December 21st, 2017|Categories: Announcement, News, Press|

A medication used to treat joint and skin conditions might also help people whose only hope of surviving cancer is receiving stem cells from a donor, according to research by a University of British Columbia scientist. Transplants of blood stem cells, which can differentiate into all types of blood cells, can be a cure for life-threatening blood cancers like leukemia or lymphoma. But the treatment is often not pursued, because typical donations a often from umbilical cord blood a are unlikely to take root in a patienta s bone marrow and grow into a self-sustaining, blood-forming system. Researchers at UBC and [...]

Read More

About Us BCRegMed

  • BC Regenerative Medicine Initiative
    Vancouver, BC
    Canada

  • 604-675-8000 x 7764
  • [email protected]
  • Monday - Friday: 9:00 AM - 5:00 PM
Go to Top